---
author: Marisa Aigen
category: tech
date: '2025-11-27 15:21:00'
description: Rising global incidence of myeloproliferative diseases boosts demand
  for specialized treatments. Breakthroughs in JAK inhibitors and thrombopoietin receptor
  agonists enhance disease management. The push towards personalized medicine and
  greater research inves‚Ä¶
importance: 3
layout: tech_news_article
original_title: Essential Thrombocythemia Global Market Analysis and Forecast, 2025-2035
  - Innovative Research in Gene Therapies Paves New Pathways for ET Management
publishedAt: '2025-11-27T15:21:00+00:00'
slug: essential-thrombocythemia-global-market-analysis-a
source:
  emoji: üì∞
  id: null
  name: GlobeNewswire
title: Essential Thrombocythemia Global Market Analysis and Forecast, 2025-2035 -
  Innovative Research in Gene Therapies Paves New Pathways for ET Management
url: https://www.globenewswire.com/news-release/2025/11/27/3195788/28124/en/Essential-Thrombocythemia-Global-Market-Analysis-and-Forecast-2025-2035-Innovative-Research-in-Gene-Therapies-Paves-New-Pathways-for-ET-Management.html
urlToImage: https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7
urlToImageBackup: https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7
---

Rising global incidence of myeloproliferative diseases boosts demand for specialized treatments. Breakthroughs in JAK inhibitors and thrombopoietin receptor agonists enhance disease management. The push towards personalized medicine and greater research inves‚Ä¶

---

[ƒå√≠st p≈Øvodn√≠ ƒçl√°nek](https://www.globenewswire.com/news-release/2025/11/27/3195788/28124/en/Essential-Thrombocythemia-Global-Market-Analysis-and-Forecast-2025-2035-Innovative-Research-in-Gene-Therapies-Paves-New-Pathways-for-ET-Management.html)

**Zdroj:** üì∞ GlobeNewswire
